BeiGene Signs Blockbuster $1.4 Billion Deal with Celgene for PD-1 Asset

Life Science

CFDA Accepts Athenex’s IND Filing for Oral Paclitaxel

Life Science

BeiGene Initiates Pivotal Trial of PD-1 Antibody BGB-A317 in China in Patients with Urothelial Cancer

Life Science

Eye Gene Therapy Firm NightstaRx Nabs Another $45 Million

Life Science

HK set to play key role in Southeast Asia growth

Financial Service, Life Science, Mining, Real Estate

DelMar Pharmaceuticals Joins National Brain Tumor Society’s Research Roundtable

Life Science

Vivace Therapeutics Comes Out of Stealth With $25M for Cancer Drugs

Life Science

China’s iCarbonX Invests in HealthLoop’s $8.4 Million B Round

Life Science, Technology

AGIC Capital To Acquire US Pharmaceutical Firm Ritedose For Asian Expansion

Life Science

BGI’s $250 Million Shenzhen IPO Scheduled for July

Life Science

Chi-Med Initiates a Phase I/II Clinical Trial of Novel FGFR Inhibitor HMPL 453 in China

Life Science

AI Can Screen Lung Cancer More Accurately than Doctors, Claims Tencent’s Pony Ma

Life Science, Technology

Athenex, a US-China Cancer Company, Stages $66 Million US IPO

Life Science

Evasc Neurovascular Closes $7.5 Million Round Led by China Investor

Life Science

ACEA Biosciences Announces Successful Completion of Phase I Clinical Study of Novel Autoimmune Disease Drug

Life Science